Usage and safety of fingolimod in multiple sclerosis

被引：0
|
作者：
Nieves Sedano, M. [1 ]
Caro Teller, J. M. [1 ]
Fernandez Redondo, D. [1 ]
Garcia Munoz, C. [1 ]
Lazaro Cebas, A. [1 ]
Pablos Bravo, S. [1 ]
Alioto, D. [1 ]
Gomez Valbuena, I. [1 ]
Ferrari Piquero, J. M. [1 ]
机构：
[1] Hosp 12 Octubre, E-28041 Madrid, Spain
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2016年 / 38卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PT053
引用
收藏
页码：588 / 589
页数：2
相关论文
共 50 条
  • [31] Severe multiple sclerosis relapse on fingolimod
    Nealon, N.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S230 - S231
  • [32] REGIONAL EFFICACY OF FINGOLIMOD IN MULTIPLE SCLEROSIS
    Bogdan, Iulia
    Warren, Catherine
    Koniotes, Anna
    Ruffer, Giles
    Newell, Bettina
    Fisniku, Leonora
    Bremner, Stephen
    Gabel, Matt C.
    Rashid, Waqar
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A42 - A43
  • [33] Safety and efficacy of fingolimod in clinical practice-Experience of the multiple sclerosis center in Lebanon
    Yamout, Bassem I.
    Zeineddine, Maya M.
    Tamim, Hani
    Khoury, Samia J.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP18 - NP19
  • [34] Efficacy and Safety of Fingolimod in Hispanic Patients with Multiple Sclerosis: Pooled Clinical Trial Analyses
    Martinez, Angel R. Chinea
    Correale, Jorge
    Coyle, Patricia K.
    Meng, Xiangyi
    Tenenbaum, Nadia
    ADVANCES IN THERAPY, 2014, 31 (10) : 1072 - 1081
  • [35] MULTIPLE SCLEROSIS DRUG FINGOLIMOD RECEIVES NEW SAFETY WARNINGS RELATED TO CARDIOVASCULAR RISK
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2012, 112 (09) : 23 - 24
  • [36] Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis
    Gajofatto, Alberto
    Turatti, Marco
    Monaco, Salvatore
    Benedetti, Maria Donata
    DRUG HEALTHCARE AND PATIENT SAFETY, 2015, 7 : 157 - 167
  • [37] Efficacy and Safety of Fingolimod in Hispanic Patients with Multiple Sclerosis: Pooled Clinical Trial Analyses
    Angel R. Chinea Martinez
    Jorge Correale
    Patricia K. Coyle
    Xiangyi Meng
    Nadia Tenenbaum
    Advances in Therapy, 2014, 31 : 1072 - 1081
  • [38] Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study
    Paolicelli, Damiano
    Manni, Alessia
    Direnzo, Vita
    D'Onghia, Mariangela
    Tortorella, Carla
    Zoccolella, Stefano
    Trojano, Maria
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (10): : 1131 - 1136
  • [39] Impact of fingolimod on comorbid migraine in multiple sclerosis
    Cavalla, P.
    Binello, E.
    Masera, S.
    Mattioda, A.
    Superti, G.
    Romagnolo, A.
    Vercellino, M.
    Vallelonga, F.
    Marino, L.
    Pinessi, L.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 251 - 252
  • [40] Effectiveness of alternative dose fingolimod for multiple sclerosis
    Longbrake, Erin E.
    Kantor, Daniel
    Pawate, Siddharama
    Bradshaw, Michael J.
    von Geldern, Gloria
    Chahin, Salim
    Cross, Anne H.
    Parks, Becky J.
    Rice, Marc
    Khoury, Samia J.
    Yamout, Bassem
    Zeineddine, Maya
    Russell-Giller, Shira
    Caminero-Rodriguez, Ana
    Edwards, Keith
    Lathi, Ellen
    VanderKodde, Danita
    Meador, William
    Berkovich, Regina
    Ge, Lily
    Bacon, Tamar E.
    Kister, Ilya
    NEUROLOGY-CLINICAL PRACTICE, 2018, 8 (02) : 102 - 107
12345